Copy article

Weight-loss medication is becoming the perk employees are asking for and employers need a plan before it lands in their inbox

ended 01. March 2026

What’s going on

There’s a noticeable spike in requests and chatter about employers funding weight-loss medication (GLP-1 drugs like Ozempic and Mounjaro) as part of benefits packages. For some employees, it’s being framed as “wellbeing support”. For some employers, it’s being pitched as a productivity and absence-reduction play.

Either way, this is drifting from “trendy topic” into “real workplace request”. And once it’s in the mix, you cannot treat it like a gym discount or a fruit bowl.

Why this matters for employers

This is medical treatment, not a lifestyle perk

The moment medication is involved, you are into clinical territory: prescribing pathways, side effects, monitoring, fitness for work discussions, and sensitive medical information. Even if it sits under a benefits provider, you still need a clear employer stance on what you do and do not get involved in.

Equality Act risk is sitting right underneath the surface

Weight is not a protected characteristic on its own. But disability discrimination can come into play where someone has an impairment with a substantial and long-term impact on day-to-day activities. Weight-related conditions can overlap with that. So can mental health and eating disorders. You need to assume this topic can trigger Equality Act duties, even when the initial request sounds like “I just want to lose weight”.

Culture and stigma can become your biggest risk

This is the kind of benefit that can go toxic quickly if managers start commenting on bodies, making “helpful” suggestions, or treating weight loss as a performance improvement plan. If you offer anything in this space, you need manager guidance that is crystal clear: no jokes, no nudges, no judgement, no “well maybe you should…”.

Fairness, cost, and the “why that and not this?” problem

If you fund one type of medical support, employees will compare it to other support you do or do not fund (menopause support, fertility, neurodiversity assessments, mental health treatment, physiotherapy, diabetes support, etc.). If your eligibility rules are vague, you risk a two-tier benefit that causes resentment.

The private medical insurance question (this is where it gets messy)

If you already have private medical insurance (PMI), employees will ask two very direct questions:

  • Does our PMI cover weight-loss medication?
  • If I take it and I get side effects, is any follow-up treatment covered too?

This is where employers get caught out, because PMI coverage varies massively by insurer and policy wording. Some policies exclude weight management treatments, some only cover certain conditions, and some will treat complications and side effects differently. If you do not know your current policy position, you will end up answering confidently and incorrectly, which is an avoidable own goal.

The SME recruitment and retention angle (this is where it gets real)

Small businesses are already fighting for talent against bigger employers with glossy benefits packages. So this creates a new pressure point:

Recruitment quality

A strong candidate asking for GLP-1 medication support as a perk is going to force a decision: do you match the ask, offer an alternative, or risk losing them to a bigger employer who can say yes in 30 seconds?

Retention

If an employee you do not want to lose says they are considering leaving because another employer offers it, you are suddenly making a commercial decision, not a “well-being” decision. And if you say yes for retention reasons, you then have to explain why it is not available to everyone else.

This is exactly how “one-off arrangements” become equality and morale problems.

Questions to be answered

  1. Would you ever include weight-loss medication in your benefits package, or is it a hard no? What’s driving your decision: cost, ethics, culture, or risk?
  2. If you already offer private medical insurance, do you actually know whether it covers weight-loss medication, or are you assuming?
  3. If an employee experiences side effects and needs further treatment, do you expect your PMI to cover that, and have you checked the small print?
  4. If a high-quality candidate asked for this as a perk during recruitment, would you negotiate, say no, or offer an alternative benefit instead?
  5. If a key employee said they were leaving for a competitor who offers it, would you match it to retain them, or hold the line for fairness?
  6. If you agreed to it for one person to secure or retain talent, how would you stop it becoming a two-tier perk that causes resentment?
  7. Who would own decisions like this in your business: HR, reward, finance, occupational health, or your benefits broker?
  8. If you did offer support, would you insist it includes clinical oversight and coaching, or would you fund medication only? What safeguards would you put around it?

Sources (URLs)

https://www.hrgrapevine.com/content/article/2026-02-26-weighing-up-weight-loss-benefits-provision 

https://www.hrgrapevine.com/content/article/2026-01-22-employees-demand-ozempic-want-their-bosses-to-pay 

https://www.gov.uk/government/publications/equality-act-guidance/disability-equality-act-2010-guidance-on-matters-to-be-taken-into-account-in-determining-questions-relating-to-the-definition-of-disability-html 

https://www.equalityhumanrights.com/equality/equality-act-2010/your-rights-under-equality-act-2010/disability-discrimination 

https://curia.europa.eu/juris/document/document.jsf?docid=155125&doclang=EN 

3 responses from the Newspage community

Copy all

Star Quote
Copy

Editor
Kate UnderwoodVerified
Founder & Chief People Strategist at Kate Underwood HR and Training
Ozempic at work isn’t a quirky perk. It’s a prescription. And SMEs do not need that extra complication right now. GLP-1 meds aren’t a fruit bowl upgrade. They come with prescribing rules, side effects, monitoring and time off when someone feels rough. Even if a provider delivers it, your managers still get the messy chats: “I’m on this, I’m dizzy, I can’t drive, I’m struggling.” Now you’re into fitness-for-work calls, possible adjustments, and handling sensitive medical info. That’s risk, not wellbeing glitter. And don’t hide behind “weight isn’t protected.” True. But disability discrimination can land fast when there’s long-term conditions, mental health, mobility issues, diabetes, or eating disorder history in the mix. Let managers nudge it for “productivity” and you’ve built stigma into your culture.
If asked by staff or candidates: “We don’t fund prescription weight-loss meds. We do offer X support and signpost to GP/PMI.” Keep it consistent. No body chat.
Copy

Editor
Sarah GatfordVerified
The Positivity Pathfinder - Head of Interactions at Sarah Gatford Ltd
Everyone's asking who pays and who qualifies. But before employers weigh up weight-loss medication as a workplace benefit, there's a less visible question worth asking, what culture are you creating around it? How managers talk about bodies, health, and wellbeing will matter far more than the policy wording. Get the communication wrong, and even a well-intentioned benefit becomes a liability.
Copy

Rohit Parmar-MistryVerified
Founder at Pattrn Data
Weight loss meds as a perk sound shiny, but they drag employers into clinical territory they are not set up to govern. This is healthcare, not free fruit 2.0. In our audits, we see GLP 1 funding quietly offered to higher earners first while lower paid staff are told to try the wellbeing app, which is a two tier culture risk waiting for a tribunal. Before anyone talks recruitment or retention, you need answers on PMI coverage, clinical oversight, side effect follow up and how this sits with your Equality Act duties and weight stigma. My take: do not add GLP 1s to the benefits menu until HR, finance and your broker own a single, clinical standard and you can defend who gets it, why and what happens when it goes wrong.